Rapport Therapeutics, Inc. RAPP Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s investment proceeds?
- Rapport Therapeutics, Inc. (RAPP) reported investment proceeds of $58.32M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Rapport Therapeutics, Inc.'s investment proceeds decreased by 9.7% year-over-year, from $64.56M to $58.32M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.